期刊文献+

子宫内膜癌组织中COX-2表达及微血管密度与预后的关系

The Relationships Between Expression of COX-2,Microvessel Density and the Prognosis of Endometrial Carcinoma
下载PDF
导出
摘要 目的探讨子宫内膜癌组织中COX-2表达及微血管密度(MVD)与子宫内膜癌预后的关系。方法采用免疫组化SP法检测60例子宫内膜癌组织中COX-2表达及MVD值,分析其与预后的关系。结果Kaplan-Meier曲线法生存分析结果显示,COX-2阳性表达者生存率较COX-2阴性表达者降低(P<0.05);MVD≥35者生存率较MVD<35者明显降低(P<0.05)。COX回归分析结果显示,COX-2、MVD、手术病理分期、组织分化级别、肌层浸润深度均是子宫内膜癌的独立预后因素。结论COX-2阳性表达及高水平MVD者预后较COX-2阴性表达及低水平MVD者预后差,COX-2和MVD均是子宫内膜癌的独立预后因素。 Objective To explore the relationships between expression of COX-2,MVD and the prognosis of patients with endometrial carcinoma.Methods COX-2 expression in endometrial carcinoma tissue were detected by SP immunohistochemical method in 60 patients.The relationships between COX-2 expression,MVD and prognosis were analyzed.Results Kaplan-Meier survival analysis showed that survival rate in patients with COX-2 positive was significantly lower than that with COX-2 negative(P〈0.05);survival rate in patients with MVD≥35 was significantly lower than that with with MVD〈35(P〈0.05).COX regression analysis showed that COX-2,MVD,Histological differentiation,oporation stage metastasis of lymphnode,myometrial invation were the independent prognostic factors for endometrial carcinoma.Conclusion High expression of COX-2 and high level of MVD are associated with poor survival of patients with endometrial carcinoma.COX-2 and MVD are one of independent prognostic factors for endometrial carcinoma.
出处 《江西医学院学报》 2009年第11期32-34,共3页 Acta Academiae Medicinae Jiangxi
关键词 子宫内膜癌 COX-2 微血管密度 预后 免疫组化 endometrial carcinoma COX-2 microvascular density prognosis immunohistochemistry
  • 相关文献

参考文献8

  • 1Fujiwaki R, Iida K, Kanasaki H, et al. Cyclooxygenase-2 Expression in Endometrial Cancer: Correlation with Microvessel Count and Expression of Vascular Endothelial Growth Factor and Thymidine Phosphorylase[J ]. Hum Pathol, 2002,33 (2): 213 -219.
  • 2Ohno Y,Ohno S, Suzuki N, etal. Role of Cyclooxygenase-2 in Immunomodulation and Prognosis of Endometrial Carcinoma [J]. Int J Cancer,2005,114(5) :696- 701.
  • 3Giatromanolaki A,Siviridis E, IKoukourakis M I, et al. Introtu moral Angiogenesis: a New Prognostic Indicator for Stage l Endometrial Adenocarcinoma[J]. Oncol Res, 1999,11 (4) : 205- 212.
  • 4Kumar S, Ghellal A, I.i C, et al. Breast Carcinoma: Vascular Density Determined Using CD105 Antibody Correlates with Tumor Prognosis[J]. Cancer Res, 1999,59(4) :856-861.
  • 5Kosaka T, Miyata A, Ihara H, et al. Characterization of the Human Gene(PTGS 2) Encoding Prostaglandin-endoperoxide Synthase[J]. Eur J lgiochem, 1994 ,221(3) :889-897.
  • 6Gao J, Niwa K, Takemura M, el al. Significant Anti-proliferation of Human Endometrial Cancer Cells by Combined Treat- ment with a Selective COX 2 Inhibitor NS 398 and Specific MEK Inhibitor U0126[J]. Int J Oncol,2005,26(3):737-744.
  • 7Arango H A, Icely S, Roberts W S, et al. Aspirin Effeets on Endometrial Cancer Cell Growth[J]. Obstet ynecol, 2001,97 (3) :423-427.
  • 8man J, Watson K, Ingber D, et al. Induction of Angiogene the Transition from Hyperplasia to Neoplasia[J]. 339(6219):58-61.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部